Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Conditions associated with elevated B12 levels include: Liver disease : Hepatocellular damage releases stored B12 into circulation, with levels correlating with disease severity in conditions such as cirrhosis, hepatitis, and hepatocellular carcinoma Renal impairment : Reduced kidney function decreases B12 clearance, leading to accumulation Haematological malignancies : Myeloproliferative disorders, acute leukaemia, and polycythaemia vera can elevate B12 through increased production of B12-binding proteins (transcobalamins) Solid tumours : Certain cancers, particularly those affecting the liver or gastrointestinal tract, may elevate B12 levels A specific concern relates to cyanocobalamin in patients with Leber's hereditary optic neuropathy , a rare mitochondrial disorder
It drops as the dose climbs
As peptide therapy continues to gain momentum in 2026, the combination of BPC-157 and TB-500 in a nasal spray format has emerged as one of the most sought-after solutions for those seeking enhanced recovery, tissue repair, and overall wellness support
that data belongs to the copper-tripeptide class, not to AHK-Cu itself
The administration is non-invasive and requires no injections, medical devices, or surgical tools
US$ 26.62
US$ 26.69
US$ 27.49
US$ 20.49
US$ 28.85
US$ 24.39
US$ 22.07
US$ 23.19
US$ 28.91
US$ 27.87
